Detalhe da pesquisa
1.
Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.
Clin Infect Dis
; 67(12): 1883-1889, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767684
2.
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
J Antimicrob Chemother
; 73(6): 1672-1676, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29584910
3.
Integrating Human Immunodeficiency Virus-Specific Elements in the Treatment of Tobacco Dependence (ANRS 144 Inter-ACTIV).
Clin Infect Dis
; 75(10): 1868-1871, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789259
4.
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
J Antimicrob Chemother
; 71(2): 490-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26568566
5.
Realist evaluation of a theory-based life skills programme aiming to prevent addictive behaviours in adolescents: the ERIEAS study protocol.
BMJ Open
; 10(6): e034530, 2020 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601111
6.
Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).
Pharmacoecon Open
; 3(4): 505-515, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968368
7.
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.
Lancet HIV
; 5(3): e126-e135, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29329763